ORTIN GLOBAL LIMITED Financial Ratios
ORTINGLOBE · Healthcare · Current price ₹15.33
P/E ratio
-13.5x
P/B ratio
10.9x
ROE
-59.7%
ROCE
-32.1%
Debt / Equity
0.81
Dividend yield
0.0%
Ratio reference
| Ratio | Value | What it means |
|---|---|---|
| P/E | -13.5x | Price paid per ₹1 of annual earnings — lower is cheaper (context-dependent). |
| P/B | 10.9x | Price relative to book value — <1 can signal deep value or trouble. |
| ROE | -59.7% | Return on equity — how much profit the company earns on shareholder capital. |
| ROCE | -32.1% | Return on capital employed — efficiency including debt. >15% is strong. |
| D/E | 0.81 | Leverage — higher means more debt-funded, riskier in downturns. |
Model it yourself — PEG Ratio Calculator
Opens pre-filled with ORTIN GLOBAL LIMITED's latest numbers.
ORTIN GLOBAL LIMITED profitability
ORTIN GLOBAL LIMITED generates a return on equity of -59.7% and a return on capital employed of -32.1%. An ROE consistently above 15% usually points to a quality business with a durable advantage; below 10% suggests weak profitability or a capital-heavy model.
Leverage & valuation
With a debt-to-equity of 0.81 and a P/E of -13.5x, ORTIN GLOBAL LIMITED is moderately leveraged. Our overall business-quality score for the company is 1.9 / 10.
Understand the ratios
More on ORTIN GLOBAL LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.